CIK 0000879407 · Large accelerated filer
ARROWHEAD PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- ARWR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Sep 30
- Incorporated
- DE
- Entity type
- operating
- EIN
- 460408024
- Phone
- 626-696-4702
- Business address
- 177 E COLORADO BLVD, SUITE 700, PASADENA, CA, 91105
- Former names
- ARROWHEAD RESEARCH CORP, INTERACTIVE GROUP INC, INTERACTIVE INC
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 8-K Event Executive or director change
- 4 Open-market sale Chief Executive Officer sold 141,122 shares at an average $10.87 ($1,533,337)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 8-K Event Shareholder vote results
- 4 Open-market sale Chief Executive Officer sold 51,425 shares at $15.07 ($774,975)
- 144 Insider Sale of Securities
- 424B7 Offering Prospectus
- 4 Planned sale Chief Executive Officer sold 300,000 shares at an average $17.58 ($5,274,334)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- SCHEDULE 13D Stake Beneficial Ownership Report
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 4 Grant or award Chief Executive Officer acquired 9,550 shares (grant or award)
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- 4 Grant or award Director acquired 38,396 shares (grant or award)
- 3 Insider Initial Statement of Ownership
Page 7 of 69 · 1,363 filings